In bladder cancer, FGFR3 mutations predominantly occur in low-grade, non-muscle-invasive subtypes with papillary growth patterns and well-differentiated histology, suggesting they may define a distinct molecular subtype. The gene discussed is FGFR3; the disease is urinary bladder carcinoma.